1
|
John JD, Nishimoto S, Kadowaki N, Saito I, Okano K, Okano S, Zahn DRT, Masuzawa T, Yamada T, Chua DHC, Ito T. Quantum device designing (QDD) for future semiconductor engineering. Rev Sci Instrum 2022; 93:034703. [PMID: 35365006 DOI: 10.1063/5.0081544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Accepted: 02/21/2022] [Indexed: 06/14/2023]
Abstract
In semiconductor device history, a trend is observed where narrowing and increasing the number of material layers improve device functionality, with diodes, transistors, thyristors, and superlattices following this trend. While superlattices promise unique functionality, they are not widely adopted due to a technology barrier, requiring advanced fabrication, such as molecular beam epitaxy and lattice-matched materials. Here, a method to design quantum devices using amorphous materials and physical vapor deposition is presented. It is shown that the multiplication gain M depends on the number of layers of the superlattice, N, as M = kN, with k as a factor indicating the efficiency of multiplication. This M is, however, a trade-off with transit time, which also depends on N. To demonstrate, photodetector devices are fabricated on Si, with the superlattice of Se and As2Se3, and characterized using current-voltage (I-V) and current-time (I-T) measurements. For superlattices with the total layer thicknesses of 200 nm and 2 μm, the results show that k200nm = 0.916 and k2μm = 0.384, respectively. The results confirm that the multiplication factor is related to the number of superlattice layers, showing the effectiveness of the design approach.
Collapse
Affiliation(s)
- J D John
- Department of Physics, International Christian University, 3-10-2 Osawa, Mitaka, Tokyo 181-8585, Japan
| | - S Nishimoto
- Department of Physics, International Christian University, 3-10-2 Osawa, Mitaka, Tokyo 181-8585, Japan
| | - N Kadowaki
- Department of Physics, International Christian University, 3-10-2 Osawa, Mitaka, Tokyo 181-8585, Japan
| | - I Saito
- Department of Physics, International Christian University, 3-10-2 Osawa, Mitaka, Tokyo 181-8585, Japan
| | - K Okano
- Department of Physics, International Christian University, 3-10-2 Osawa, Mitaka, Tokyo 181-8585, Japan
| | - S Okano
- Semiconductor Physics, Chemnitz University of Technology, D-09107 Chemnitz, Germany
| | - D R T Zahn
- Semiconductor Physics, Chemnitz University of Technology, D-09107 Chemnitz, Germany
| | - T Masuzawa
- Research Institute of Electronics, Shizuoka University, 3-5-1 Johoku, Naka-ku, Hamamatsu 432-8011, Japan
| | - T Yamada
- Nanomaterials Research Institute, National Institute of Advanced Industrial Science and Technology, 1-1-1 Higashi, Tsukuba 305-8565, Japan
| | - D H C Chua
- Department of Material Science and Engineering, National University of Singapore, 9 Engineering Drive, Singapore 119077
| | - T Ito
- Eiwa Bussan Company Limited, 2-9-14 Uchikanda, Chiyoda-ku, Tokyo, Japan
| |
Collapse
|
2
|
Jones M, Okano S, Looke D, Kennedy G, Pavilion G, Clouston J, Van Kuilenburg R, Geary A, Joubert W, Eastgate M, Mollee P. Catheter-associated bloodstream infection in patients with cancer: comparison of left- and right-sided insertions. J Hosp Infect 2021; 118:70-76. [PMID: 34656663 DOI: 10.1016/j.jhin.2021.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2021] [Revised: 09/26/2021] [Accepted: 10/01/2021] [Indexed: 11/26/2022]
Abstract
BACKGROUND There is limited research on the relationship between side of insertion of central venous catheter (CVAD) and bloodstream infection risk in patients with cancer. AIM To conduct an exploratory analysis of data from a randomized control trial (RCT) and data from a prospective cohort study to compare infection rates for right- and left-sided insertions. METHODS The study populations were patients aged >14 years with cancer from two tertiary hospitals in Brisbane, Australia. The primary endpoint was catheter-associated bloodstream infection (CABSI) adjudicated by blinded assessors. For the RCT, randomized intention-to-treat comparisons were conducted between left- and right-side allocated insertion for early (≤14 days) and late (>14 days) infection using Cox proportional hazards regression. The RCT data were also combined with cohort study data collected from one of the hospitals prior to the RCT and non-randomized comparisons conducted between left- and right-sided insertions. FINDINGS In 634 randomly allocated CVADs there were 141 CABSIs. Analysis showed strong evidence of right-side allocated insertions having an increased risk of early infection by 2.5 times (95% confidence interval (CI): 1.3-4.7); however, there was no evidence of increased risk for late infection (hazard ratio: 1.06; 95% CI: 0.71-1.59). Results from analysis of the RCT and cohort study data combined (2786 CVADs and 385 CABSIs) were similar. CONCLUSION There appears to be an increased risk of CABSI in patients with cancer for CVAD inserted into the right-side for around two weeks after line insertion. The mechanism underpinning the increased risk is unknown.
Collapse
Affiliation(s)
- M Jones
- Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Australia.
| | - S Okano
- Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - D Looke
- School of Medicine, University of Queensland, Brisbane, Australia; Department of Infectious Diseases, Princess Alexandra Hospital, Brisbane, Australia
| | - G Kennedy
- School of Medicine, University of Queensland, Brisbane, Australia; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
| | - G Pavilion
- Department of Interventional Radiology, Princess Alexandra Hospital, Brisbane, Australia
| | - J Clouston
- Department of Interventional Radiology, Royal Brisbane and Women's Hospital, Brisbane, Australia
| | - R Van Kuilenburg
- Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia
| | - A Geary
- Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
| | - W Joubert
- Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia
| | - M Eastgate
- Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
| | - P Mollee
- School of Medicine, University of Queensland, Brisbane, Australia; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia
| |
Collapse
|
3
|
Burke JP, Pham T, May S, Okano S, Ratanjee SK, Thet Z, Wong JKW, Venuthurupalli S, Ranganathan D. Kidney biopsy practice amongst Australasian nephrologists. BMC Nephrol 2021; 22:291. [PMID: 34445981 PMCID: PMC8390249 DOI: 10.1186/s12882-021-02505-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Accepted: 08/14/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Percutaneous kidney biopsy is the gold standard investigation for the diagnosis of kidney diseases. The associated risks of the procedure depend on the skill and experience of the proceduralist as well as the characteristics of the patient. The Kidney Health Australia - Caring for Australasians with Renal Impairment (KHA-CARI) guidelines on kidney biopsies, published in 2019, are the only published national kidney biopsy guidelines. As such, this study surveys current kidney biopsy practices in Australasia and examines how they align with the Australian guidelines, as well as international biopsy practice. METHODS A cross-sectional, multiple-choice questionnaire was developed examining precautions prior to kidney biopsy; rationalisation of medications prior to kidney biopsy; technical aspects of kidney biopsy; complications of kidney biopsy; and indications for kidney biopsy. This was distributed to all members of the Australian and New Zealand Society of Nephrology (ANZSN). RESULTS The response rate for this survey is approximately 21.4 % (182/850). Respondents found agreement (> 75.0 %) in only six out of the twelve questions (50.0 %) which assessed their practice against the KHA-CARI guidelines. CONCLUSIONS This is the first study of its kind where kidney biopsy practices are examined against a clinical guideline. Furthermore, responses showed that practices were incongruent with guidelines and that there was a lack of consensus on many issues.
Collapse
Affiliation(s)
- J P Burke
- Kidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - T Pham
- Kidney Health Service, Rockhampton Base Hospital, Rockhampton, QLD, Australia
| | - S May
- Kidney Health Service, Tamworth Hospital, Tamworth, NSW, Australia
| | - S Okano
- Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia
| | - S K Ratanjee
- Kidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - Z Thet
- Kidney Health Service, Rockhampton Base Hospital, Rockhampton, QLD, Australia.,School of Medicine, Griffith University, Brisbane, QLD, Australia.,School of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - J K W Wong
- Renal Unit, Liverpool Hospital, Liverpool, NSW, Australia
| | - S Venuthurupalli
- School of Medicine, University of Queensland, Brisbane, QLD, Australia.,Kidney Health Service, Ipswich Hospital, Ipswich, QLD, Australia
| | - D Ranganathan
- Kidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. .,School of Medicine, Griffith University, Brisbane, QLD, Australia.
| |
Collapse
|
4
|
Jacobs NF, Veronese LR, Okano S, Hurst C, Dyer RA. The incidence of postoperative nausea and vomiting after caesarean section in patients with hyperemesis gravidarum: a retrospective cohort study. Int J Obstet Anesth 2020; 44:81-89. [PMID: 32823251 DOI: 10.1016/j.ijoa.2020.07.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Revised: 05/22/2020] [Accepted: 07/15/2020] [Indexed: 11/26/2022]
Abstract
BACKGROUND Postoperative nausea and vomiting is one of the most common anaesthetic complications of caesarean section. This study examined the association between hyperemesis gravidarum during pregnancy and nausea and vomiting after caesarean section. METHODS A single-centre, retrospective cohort study, using electronic databases of patients with and without hyperemesis gravidarum, undergoing caesarean section from 2015 to 2019. The incidence and severity of postoperative nausea and vomiting were established by a review of the documentation of administration of postoperative anti-emetics within the 24-h period after surgery, and examined using univariable, multivariable binary and ordered logistic regression models. RESULTS Data were compared for 76 patients with hyperemesis gravidarum and 315 patients without the condition. The incidence of postoperative nausea and vomiting in the hyperemesis group versus the non-hyperemesis group was 43.4% vs 29.6%, respectively. The odds of experiencing postoperative nausea and vomiting was 1.95 times higher in women with hyperemesis gravidarum than in those without (aOR 1.95, 95% CI 1.13 to 3.36, P=0.016). The odds of having more severe postoperative nausea and vomiting were greater in the hyperemesis gravidarum group (aOR 1.91, 95% CI 1.14 to 3.20, P=0.014). CONCLUSION Patients with hyperemesis gravidarum are more likely to develop nausea and vomiting after caesarean section, and this is likely to be of greater severity than in those without the condition. This finding should assist the effective provision of intra-operative and postoperative anti-emetics for patients with hyperemesis gravidarum undergoing caesarean section.
Collapse
Affiliation(s)
- N F Jacobs
- Department of Anaesthesia, Mater Health Services, South Brisbane, QLD, Australia.
| | - L R Veronese
- Department of Anaesthesia, Redland Hospital, Cleveland, QLD, Australia
| | - S Okano
- Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia
| | - C Hurst
- Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia
| | - R A Dyer
- Department of Anaesthesia and Perioperative Medicine, University of Cape Town, Cape Town, South Africa
| |
Collapse
|
5
|
Ikeda T, Aida M, Yoshida Y, Matsumoto S, Tanaka M, Nakayama J, Nagao Y, Nakata R, Oki E, Akahoshi T, Okano S, Nomura M, Hashizume M, Maehara Y. Alteration in faecal bile acids, gut microbial composition and diversity after laparoscopic sleeve gastrectomy. Br J Surg 2020; 107:1673-1685. [DOI: 10.1002/bjs.11654] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 03/02/2020] [Accepted: 04/06/2020] [Indexed: 12/20/2022]
Abstract
Abstract
Background
Laparoscopic sleeve gastrectomy (LSG) is a well established treatment for severe obesity and type 2 diabetes. Although the gut microbiota is linked to the efficacy of LSG, the underlying mechanisms remain elusive. The effect of LSG for morbid obesity on the gut microbiota and bile acids was assessed here.
Methods
Severely obese subjects who were candidates for LSG were included and followed until 6 months after surgery. The composition and abundance of the microbiota and bile acids in faeces were assessed by 16S ribosomal RNA sequencing, quantitative PCR and liquid chromatography–mass spectrometry.
Results
In total, 28 patients with a mean(s.d.) BMI of 44·2(6·6) kg/m2 were enrolled. These patients had achieved excess weight loss of 53·2(19·0) per cent and showed improvement in metabolic diseases by 6 months after LSG, accompanied by an alteration in the faecal microbial community. The increase in α-diversity and abundance of specific taxa, such as Rikenellaceae and Christensenellaceae, was strongly associated with reduced faecal bile acid levels. These changes had a significant positive association with excess weight loss and metabolic alterations. However, the total number of faecal bacteria was lower in patients before (mean(s.d.) 10·26(0·36) log10 cells per g faeces) and after (10·39(0·29) log10 cells per g faeces) operation than in healthy subjects (10·83(0·27) log10 cells per g faeces).
Conclusion
LSG is associated with a reduction in faecal bile acids and greater abundance of specific bacterial taxa and α-diversity that may contribute to the metabolic changes.
Collapse
Affiliation(s)
- T Ikeda
- Department of Integration of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, Japan
- Department of Oral Medicine Research Centre, Fukuoka, Japan
| | - M Aida
- Yakult Central Institute, Tokyo, Japan
| | - Y Yoshida
- Yakult Central Institute, Tokyo, Japan
| | | | - M Tanaka
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School, Fukuoka, Japan
| | - J Nakayama
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School, Fukuoka, Japan
| | - Y Nagao
- Department of Integration of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, Japan
| | - R Nakata
- Department of Integration of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, Japan
| | - E Oki
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - T Akahoshi
- Department of Integration of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, Japan
| | - S Okano
- Department of Pathology, Fukuoka Dental College, Fukuoka, Japan
| | - M Nomura
- Department of Medicine and Bioregulatory Science, Fukuoka, Japan
| | - M Hashizume
- Department of Integration of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, Japan
| | - Y Maehara
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| |
Collapse
|
6
|
Oyamada T, Okano S. Cytotoxicity effect of trastuzumab on canine peripheral blood mononuclear cells. Iran J Vet Res 2020; 21:263-268. [PMID: 33584838 PMCID: PMC7871734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 10/11/2020] [Accepted: 10/24/2020] [Indexed: 06/12/2023]
Abstract
BACKGROUND Trastuzumab is an antibody drug used to treat human epidermal growth factor receptor 2 (HER2) overexpressing human metastatic breast cancer. Antibody-dependent cellular cytotoxicity (ADCC) is considered to be the major mechanism of cytotoxicity of the drug. However, its ability to induce an ADCC response in canine peripheral blood mononuclear cells (PBMCs) is not well established. AIMS We aimed to evaluate the ability of trastuzumab in enhancing the cytotoxicity of PBMCs against canine tumor cells. METHODS We used canine tumor cell lines isolated from metastatic mammary gland tumors (CHMm and CIPm) and thyroid adenocarcinoma (CTAC). The binding of trastuzumab to the cells was confirmed using flow cytometry analysis. Peripheral blood mononuclear cells obtained from healthy beagles and lymphokine-activated killer (LAK) cells, generated by interleukin-2 (IL-2) stimulation of PBMCs, were used as effector cells. Standard lactate dehydrogenase (LDH) release assay was used to measure the cytotoxicity of the LAK cells against tumor cell lines in the presence of trastuzumab. RESULTS Trastuzumab enhanced the cytotoxicity of PBMCs against CHMm. Moreover, LAK cells killed CHMm synergistically in the presence of trastuzumab. However, the presence of trastuzumab did not produce such a synergistic effect when LAK cells acted against CIPm and CTAC. CONCLUSION We confirmed the ability of trastuzumab to induce an ADCC response in canine PBMCs and determined its synergistic effect with LAK cells. Although the in vitro system in the present study did not show the induction of trastuzumab-mediated ADCC response against all canine tumor cell lines, the results of this study indicate the potential antitumor activity of trastuzumab in canines.
Collapse
Affiliation(s)
- T. Oyamada
- Animal Medical Center, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, 183-0054, Japan
- Laboratory of Small Animal Surgery 2, School of Veterinary Medicine, Kitasato University, Aomori, 034-8628, Japan
| | - S. Okano
- Laboratory of Small Animal Surgery 2, School of Veterinary Medicine, Kitasato University, Aomori, 034-8628, Japan
| |
Collapse
|
7
|
Horinouchi A, Suzuki S, Kamata H, Kaneko A, Fujisawa T, Ueda Y, Enokida T, Ito K, Okano S, Makabe H, Kawasaki T, Tahara M. Evaluation of a pharmacist-led opioid de-escalation (PLODE) program after chemoradiotherapy completion in head and neck cancer patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz428.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
8
|
Enokida T, Ogawa T, Homma A, Okami K, Minami S, Iwae S, Nakanome A, Shimizu Y, Motegi A, Maki D, Ueda Y, Fujisawa T, Nomura S, Okano S, Tahara M. A multicenter phase II trial of paclitaxel, carboplatin and cetuximab (PCE) followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy287.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
9
|
Shewdin S, Bong YC, Okano S, Chatfield MD, Walsham J. A prospective observational study of the change in systemic ionised calcium following 4% citrate locking of venous haemodialysis catheters in intensive care patients. Anaesth Intensive Care 2018; 46:381-385. [PMID: 29966111 DOI: 10.1177/0310057x1804600406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Traditionally heparin has been the anticoagulant of choice for venous dialysis catheter locking. There is systemic leakage of heparin catheter locking solutions at the time of injection. Alternative agents, such as citrate, are increasingly being used. We are not aware of any data in the critical care literature on the effect of citrate locking of venous dialysis catheters on systemic ionised calcium (iCa2+). To assess the effect of 4% citrate locking of venous dialysis catheters on systemic iCa2+ in intensive care patients we performed a prospective observational study of 50 paired samples in 26 intensive care patients receiving 4% citrate dialysis catheter locking in an adult tertiary intensive care unit between May 2016 and December 2016. Arterial blood gas (ABG) analysis was performed prior to venous dialysis catheter locking and a baseline iCa2+ result obtained. The catheter was locked with 4% citrate solution. A further ABG was sampled between 30 and 120 seconds later and the iCa2+ results were compared. Patients were observed for clinical signs of hypocalcaemia. On average, there was little difference between the pre- and post-catheter locking iCa2+ (median pre-locking iCa2+ 1.19 mmol/l, mean change of +0.004 mmol/l, 95% confidence interval [CI] -0.004 to 0.013, P=0.34). There was no evidence this difference differed by length of catheter P=0.26) or site of catheter P=0.85) insertion, but there was some evidence that this differed by receipt of citrate dialysis circuit anticoagulation P=0.013). Patients who received citrate dialysis circuit anticoagulation had an increase in catheter locking iCa2+ by 0.017 mmol/l (95% CI 0.00 to 0.028). Locking of venous dialysis catheters with 4% citrate solution has no clinically significant effect on systemic iCa2+ in intensive care patients with indwelling venous dialysis catheters.
Collapse
Affiliation(s)
| | | | | | | | - J Walsham
- Senior Lecturer, University of Queensland; Brisbane, Queensland
| |
Collapse
|
10
|
McLellan EJ, Hade AD, Pelecanos A, Okano S. Introduction of a Mandatory Pre-Block Safety Checklist into a Regional Anaesthesia Block Room Service: A Quality Improvement Project. Anaesth Intensive Care 2018; 46:504-509. [DOI: 10.1177/0310057x1804600512] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Wrong-side block is an uncommon yet potentially preventable complication of regional anaesthesia. One strategy for reducing the incidence of wrong-side block is to introduce an additional check into the pre-block workflow in the form of a block ‘time out’ or ‘stop before you block’. In the aftermath of a wrong-side block incident at our institution, the mandatory use of a pre-block safety checklist was successfully introduced into the workflow of the block room. Compliance with the checklist rose from 31% in the six-month pre-intervention phase to over 90% in the six-month post-intervention phase. This was achieved without any negative effect on block efficacy, theatre efficiency, complication rates or patient satisfaction. The high rate of checklist utilisation was associated with an increased rate of ultrasound video documentation. This suggests that there may be collateral benefit to using a pre-block safety checklist in addition to merely reducing the risk of wrong-side block.
Collapse
Affiliation(s)
- E. J. McLellan
- Department of Anaesthesia and Perioperative Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland
| | - A. D. Hade
- Department of Anaesthesia and Perioperative Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland
| | - A. Pelecanos
- Biostatistician, Statistics Unit, Queensland Institute of Medical Research Berghofer, Brisbane, Queensland
| | - S. Okano
- Biostatistician, Statistics Unit, Queensland Institute of Medical Research Berghofer, Brisbane, Queensland
| |
Collapse
|
11
|
Park YT, Nogami M, Okano S. Influence of Trendelenburg position and pneumoperitoneum treatment on gastroesophageal reflux in dogs. Pol J Vet Sci 2018; 20:823-826. [PMID: 29611654 DOI: 10.1515/pjvs-2017-0104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Gastroesophageal reflux is a latent factor that may cause esophagitis, esophageal stenosis, and aspiration pneumonia through the regurgitation of the gastric fluid contents. For laparoscopic surgery, posture-changing and pneumoperitoneum operations are conducted to develop the visual field. However, few studies have examined the influence of these operations on gastroesophageal reflux. In this experiment using 10 Beagles, 10 mL of contrast medium was administered into the stomach, and the dogs were placed in the Trendelenburg position with 10-degree tilting. Pneumoperitoneum treatment with carbon dioxide was performed, with an intraperitoneal pressure of 10 mmHg. The presence or absence of gastroesophageal reflux was evaluated using computed tomography (CT). In horizontal and Trendelenburg positions, there was no reflux of Contrast medium. However, reflux was observed in the Trendelenburg position under pneumoperitoneum (p<0.05). These results suggest that the risk of gastroesophageal reflux increases during laparoscopic surgery in the Trendelenburg position with 10-degree tilting under an intraperitoneal pressure of 10 mmHg.
Collapse
Affiliation(s)
- Y T Park
- Daikanyama animal hospital, 16-15, Sarugakucho, Shibuyaku, Tokyo, 150-0033, Japan.,Laboratory of Small Animal Surgery, Kitasato University, 35-1, Higashi 23-bancho, Towada, Aomori 034-8628, Japan
| | - M Nogami
- Laboratory of Small Animal Surgery, Kitasato University, 35-1, Higashi 23-bancho, Towada, Aomori 034-8628, Japan
| | - S Okano
- Laboratory of Small Animal Surgery, Kitasato University, 35-1, Higashi 23-bancho, Towada, Aomori 034-8628, Japan
| |
Collapse
|
12
|
Ueda Y, Tahara M, Fujisawa T, Enokida T, Okano S. Platinum-Based Chemotherapy Plus Cetuximab in Patients With Recurrent or Metastatic Nasopharyngeal Cancer. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2017.12.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
13
|
Tahara M, Enokida T, Fujisawa T, Ueda Y, Okano S. Clinical Effect of Dose Escalation of Lenvatinib After Disease Progression in Patients With Metastatic Thyroid Cancer. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2017.12.199] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
14
|
Tahara H, Nishiyama Y, Okamoto S, Okano S, Tahara M. 366P Circulating microRNAs as novel promising biomarkers for early detection of tongue cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw587.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Enokida T, Fujii S, Takahashi M, Wakasugi T, Yamazaki T, Okano S, Hayashi R, Tahara M. Cytokeratin 4 is a novel predictive marker in early stage (T1/2) oral tongue squamous cell carcinoma (TSCC). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw376.20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
16
|
Tanaka K, Tokunaga E, Inoue Y, Ueo H, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Kitao H, Oki E, Oda Y, Maehara Y. Abstract P5-13-05: The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p5-13-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background.
The estrogen receptor (ER)/ GATA3/ Forkhead box A1 (FOXA1) network is necessary for the ERα functional signature specific to luminal type breast cancers. High expression of FOXA1 indicates a good prognosis in ER-positive breast cancer. However, little is known about the association between the expression of FOXA1 and GATA3, and the efficacy of neoadjuvant endocrine therapy (NAE). This study investigated their predictive potential for NAE and the changes of their expression after NAE.
Methods.
The expression of ER, progesterone receptor (PgR), Ki67, FOXA1, and GATA3 were analyzed by immunohistochemistry in 66 patients with hormone receptor-positive/ human epidermal growth factor receptor 2 (HER2)-negative breast cancer who had been treated with NAE between March 2003 and December 2012 at Kyushu University Hospital, National Kyushu Cancer Center, and Sagara Hospital. The association between the expression of biological marker and the efficacy of NAE, and their expression changes after NAE were evaluated.
Results.
The median age of the patients was 60 years (range, 30–84 years). Pre- and post-menopausal patients were 24 (36.4%) and 42 (63.6%). Endocrine agents that were administered are as follows: aromatase inhibitors (AIs) for 42 patients (63.6%), luteinizing hormone-releasing hormone (LHRH) agonist plus AI for 10 patients (15.2%), LHRH agonist plus tamoxifen for 13 patients (19.7%). NAE yielded a partial response (PR) in 21 patients (31.8%) and stable disease (SD) in 45 patients (68.2%). Breast conserving surgery was performed in 56 patients (84.8%) and mastectomy was performed in 10 patients (15.2%). Preoperative Endocrine Prognostic Index (PEPI) score was 0 in 10 patients (15.2%) and 1 or greater (score 1 ≤) in 56 patients (84.8%).
Pre-treatment FOXA1 expression was positively correlated with GATA3 (P = 0.0003) and PgR (P = 0.0138). Post-treatment Ki67 expression was significantly lower in tumors, which achieved PR compared with those with SD (P = 0.0007). The expression of PgR, Ki67, and FOXA1 was significantly lower in post-treatment tumors compared with those in pre-treatment samples (p < 0.0001, p < 0.0001 and p < 0.0001, respectively). The expression of PgR, Ki67, and FOXA1 was significantly reduced in both tumors with PR and those with SD (PR: P = 0.0004, P < 0.0001, and P = 0.0417, respectively; SD: P < 0.0001, P = 0.0001, and P < 0.0001, respectively). The expression of PgR, Ki67, and FOXA1 was significantly decreased in post-treatment tumors in both patients with the PEPI score 0 and those with score 1 ≤ (score 0: P = 0.0078, P = 0.0059, and P = 0.0098, respectively; score 1 ≤: P < 0.0001, P < 0.0001, and P = 0.0002, respectively). In tumors with PgR > 20%, the expression of Ki67 and FOXA1 were significantly lower in post-treatment tumors (P < 0.0001 and P < 0.0001, respectively).
Conclusions.
FOXA1 expression correlated with PgR expression, and was reduced significantly after NAE. These results suggest that blocking the effect of estrogen might reduce FOXA1 expression.
Citation Format: Tanaka K, Tokunaga E, Inoue Y, Ueo H, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Kitao H, Oki E, Oda Y, Maehara Y. The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P5-13-05.
Collapse
Affiliation(s)
- K Tanaka
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - E Tokunaga
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - Y Inoue
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - H Ueo
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - N Yamashita
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - Y Sagara
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - Y Ohi
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - K Taguchi
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - S Ohno
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - S Okano
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - H Kitao
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - E Oki
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - Y Oda
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| | - Y Maehara
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Graduate School of Medical Sciences, Fukuoka, Japan; Sagara Hospital, Kagoshima, Japan; National Kyushu Cancer Centre, Fukuoka, Japan
| |
Collapse
|
17
|
Nakanome A, Okano S, Wakasugi T, Enokida T, Yamazaki T, Tahara M. 316P Nonrandomized comparison between docetaxel, CDDP and 5-FU (TPF) and docetaxel, CDDP and S-1 (TPS) in locally advanced squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol 2015. [DOI: 10.1093/annonc/mdv527.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Wakasugi T, Enokida T, Nakanome A, Yamazaki T, Okano S, Tahara M. 319P The role of cetuximab maintenance after chemotherapy in patients with recurrent/metastatic squamous cell carcinoma of head and neck (R/M SCCHN): A retrospective analysis. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv527.06] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
19
|
Affiliation(s)
- S Okano
- a North Devon District Hospital, Obstetrics & Gynaecology , Raleigh Park, Barnstaple, EX31 4JB , United Kingdom
| | - I Erfan
- a North Devon District Hospital, Obstetrics & Gynaecology , Raleigh Park, Barnstaple, EX31 4JB , United Kingdom
| | - O Eskandar
- a North Devon District Hospital, Obstetrics & Gynaecology , Raleigh Park, Barnstaple, EX31 4JB , United Kingdom
| |
Collapse
|
20
|
Iwai S, Sakonju I, Okano S, Teratani T, Kasahara N, Yokote S, Yokoo T, Kobayash E. Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat. Transplant Proc 2015; 46:1578-84. [PMID: 24935331 DOI: 10.1016/j.transproceed.2013.12.068] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2013] [Revised: 10/09/2013] [Accepted: 12/16/2013] [Indexed: 12/12/2022]
Abstract
BACKGROUND Mesenchymal stem cells (MSCs) have been applied to the treatment of various diseases, and MSC administration in marginal donor grafts may help avoid the ischemia-reperfusion injury associated with solid organ transplants. Given the reports of side effects after intravenous MSC administration, local MSC administration to the target organ might be a better approach. We administered adipose tissue-derived MSCs (AT-MSCs) ex vivo to donor rat kidneys obtained after cardiac death (CD). METHODS Using male Lewis rats (8-10 weeks), and a marginal transplant model of 1hr CD plus 1hr sub-normothermic ET-Kyoto solution preservation were conducted. AT-MSCs obtained from double-reporter (luciferase-LacZ) transgenic Lewis rats were injected either systemically (1.0 × 10(6) cells/0.5 mL) to bilaterally nephrectomized recipient rats that had received a marginal kidney graft (n = 6), or locally via the renal artery (500 μL ET-Kyoto solution containing the same number of AT-MSCs) to marginal kidney grafts, which were then preserved (1 hour; 22°C) before being transplanted into bilaterally nephrectomized recipient rats (n = 8). Serum was collected to assess the therapeutic effects of AT-MSC administration, and the recipients of rats surviving to Day 14 were separately evaluated histopathologically. Follow-up was by in vivo imaging and histological LacZ staining, and tumor formation was evaluated in MSC-injected rats at 3 months. RESULTS Systemic injection of MSC did not improve recipient survival. In vivo imaging showed MSCs trapped in the lung that later became undetectable. Ex vivo injection of MSCs did show a benefit without adverse effects. At Day 14 after RTx, 75% of the rats in the AT-MSC-injected group (MSC[+]) had survived, whereas 50% of the rats in the AT-MSC-non-injected group (MSC[-]) had died. Renal function in the MSC(+) group was improved compared with that in the MSC(-) group at Day 4. LacZ staining revealed AT-MSCs attached to the renal tubules at 24 hours after RTx that later became undetectable. Histopathologic examination showed little difference in fibrosis between the groups at Day 14. No teratomas or other abnormalities were seen at 3 months.
Collapse
Affiliation(s)
- S Iwai
- Laboratory of Small Animal Surgery I, School of Veterinary Medicine, Kitasato University, Towada, Aomori, Japan.
| | - I Sakonju
- Laboratory of Small Animal Surgery I, School of Veterinary Medicine, Kitasato University, Towada, Aomori, Japan
| | - S Okano
- Laboratory of Small Animal Surgery II, School of Veterinary Medicine, Kitasato University, Towada, Aomori, Japan
| | - T Teratani
- Division of Development of Advanced Therapy, Center for Development of Advanced Medical Technology, Jichi Medical University, Shimotsuke, Tochigi, Japan
| | - N Kasahara
- Division of Development of Advanced Therapy, Center for Development of Advanced Medical Technology, Jichi Medical University, Shimotsuke, Tochigi, Japan
| | - S Yokote
- Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan
| | - T Yokoo
- Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan
| | - E Kobayash
- Division of Development of Advanced Therapy, Center for Development of Advanced Medical Technology, Jichi Medical University, Shimotsuke, Tochigi, Japan
| |
Collapse
|
21
|
Okano S, Tahara M, Onoe T, Enokida T, Yamazaki T, Zenda S. Induction Chemotherapy (Ic) with Docetaxel, Cisplatin and 5-Fluorouracil (Tpf) Followed By Chemoradiotherapy (Crt) Concurrent with Fractionated Administration of High-Dose Cisplatin for Patients with Locally Advanced Scchn: Results of a Multicenter Phase 2 Feasibility Study. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu340.20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Owaki M, Oono H, Nakajima N, Ohta G, Okano S, Kakizaki T, Yoshioka K. Morphology and Distribution of Lamellar Corpuscles in the Mesentery of the Cat. Anat Histol Embryol 2013; 43:375-8. [DOI: 10.1111/ahe.12087] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2012] [Accepted: 07/31/2013] [Indexed: 11/28/2022]
Affiliation(s)
- M. Owaki
- Inuyama Veterinarian Hospital; 29 Haguro aza Omishita Inuyama Aichi Japan
| | - H. Oono
- Oono Dog & Cat Hospital; 5-2 Kurisaki Honjo Saitama Japan
| | - N. Nakajima
- Shimodate Animal Hospital; 1246-3 Shimonakayama Chikusei Ibaraki Japan
| | - G. Ohta
- Inuyama Veterinarian Hospital; 29 Haguro aza Omishita Inuyama Aichi Japan
| | - S. Okano
- Kitasato University School of Veterinary Medicine; 35-1 Higashi 23ban-cho Towada Aomori Japan
| | - T. Kakizaki
- Kitasato University School of Veterinary Medicine; 35-1 Higashi 23ban-cho Towada Aomori Japan
| | - K. Yoshioka
- Kitasato University School of Veterinary Medicine; 35-1 Higashi 23ban-cho Towada Aomori Japan
| |
Collapse
|
23
|
|
24
|
Owaki M, Oono H, Nakajima N, Ohta G, Okano S, Kakizaki T, Yoshioka K. Scanning Electron Microscopic Study for Pore Formation of the Greater Omentum of Cats. Anat Histol Embryol 2012; 42:151-4. [DOI: 10.1111/j.1439-0264.2012.01177.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2012] [Accepted: 06/01/2012] [Indexed: 11/26/2022]
Affiliation(s)
- M. Owaki
- Inuyama Veterinarian Hospital; 29 Haguro aza Omishita; Inuyama; Aichi; Japan
| | - H. Oono
- Oono Dog and Cat Hospital; 5-2 Kurisaki; Honjo; Saitama; Japan
| | - N. Nakajima
- Shimodate Animal Hospital; 1246-3 Shimonakayama; Chikusei; Ibaraki; Japan
| | - G. Ohta
- Inuyama Veterinarian Hospital; 29 Haguro aza Omishita; Inuyama; Aichi; Japan
| | - S. Okano
- Kitasato University School of Veterinary Medicine; 35-1 Higashi 23ban-cho; Towada; Aomori; Japan
| | - T. Kakizaki
- Kitasato University School of Veterinary Medicine; 35-1 Higashi 23ban-cho; Towada; Aomori; Japan
| | - K. Yoshioka
- Kitasato University School of Veterinary Medicine; 35-1 Higashi 23ban-cho; Towada; Aomori; Japan
| |
Collapse
|
25
|
Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer. Eur J Surg Oncol 2011; 38:143-9. [PMID: 22154885 DOI: 10.1016/j.ejso.2011.11.009] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2011] [Revised: 11/17/2011] [Accepted: 11/21/2011] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND The aim of this study was to evaluate the efficacy and feasibility of preoperative chemotherapy with S-1 plus cisplatin in patients with initially unresectable locally advanced gastric cancer. METHODS We enrolled patients with initially unresectable locally advanced gastric cancer because of severe lymph node metastases or invasion of adjacent structures. Preoperative chemotherapy consisted of S-1 at 80 mg/m(2) divided in two daily doses for 21 days and cisplatin at 60 mg/m(2) intravenously on day 8, repeated every 35 days. If a tumor decreased in size, patients received 1 or 2 more courses. Surgery involved radical resection with D2 lymphadenectomy. RESULTS Between December 2000 and December 2007, 27 patients were enrolled on the study. No CR was obtained, but PR was seen in 17 cases, and the response rate was 63.0%. Thirteen patients (48.1%) had R0 resections. There were no treatment related deaths. The median overall survival time (MST) and the 3-year overall survival (OS) of all patients were 31.4 months and 31.0%, respectively. Among the 13 patients who underwent curative resection, the median disease-free survival (DFS) and the 3-year DFS were 17.4 months and 23.1%, respectively. The MST and the 3-year OS were 50.1 months and 53.8%, respectively. The most common site of initial recurrence after the R0 resection was the para-aortic lymph nodes. CONCLUSIONS Preoperative S-1 plus cisplatin can be safely delivered to patients undergoing radical gastrectomy. This regimen is promising as neoadjuvant chemotherapy for resectable gastric cancer. For initially unresectable locally advanced gastric cancer, new trials using more effective regimens along with extended lymph node dissection are necessary.
Collapse
Affiliation(s)
- K Inoue
- Department of Surgery, Kansai Medical University, Shinmachi 2-3-1, Hirakata city, Osaka 573-1191, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Yamazaki T, Ishiki H, Okano S, Zenda S, Arahira S, Kawashima M, Tahara M. 8586 POSTER Impact of Induction Chemotherapy on Local Control for Locally Advanced Nasopharyngeal Cancer. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)72228-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
27
|
Shibata Y, Okano S, Shiroza T, Tahara T, Nakazawa K, Kataoka S, Ishida I, Kobayashi T, Yoshie H, Abiko Y. Characterization of human-type monoclonal antibodies against reduced form of hemin binding protein 35 from Porphyromonas gingivalis. J Periodontal Res 2011; 46:673-81. [PMID: 21644999 DOI: 10.1111/j.1600-0765.2011.01389.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
BACKGROUND AND OBJECTIVE The gram-negative anaerobe Porphyromonas gingivalis has been implicated as an important pathogen in the development of adult periodontitis, and its colonization of subgingival sites is critical in the pathogenic process. We previously identified a 35 kDa surface protein (hemin binding protein 35; HBP35) from P. gingivalis that exhibited coaggregation activity, while additional analysis suggested that this protein possessed an ability to bind heme molecules. For development of passive immunotherapy for periodontal diseases, human-type monoclonal antibodies have been prepared using HBP35 as an antigen in TransChromo mice. In the present study, we focused on a single antibody, TCmAb-h13, which is known to inhibit heme binding to recombinant HBP35. The aim of our investigation was to clarify the redox-related function of HBP35 and consider the benefits of human-type monoclonal antibodies. MATERIAL AND METHODS To examine the antigen recognition capability of TCmAbs with immunoblotting and Biacore techniques, we used the native form as well as several Cys-to-Ser variants of recombinant HBP35. RESULTS We found that the redox state of recombinant HBP35 was dependent on two Cys residues, (48) C and (51) C, in the thioredoxin active center (WCGxCx). Furthermore, TCmAb-h13 recognized the reduced forms of recombinant HBP35, indicating its inhibitory effect on P. gingivalis growth. CONCLUSION Hemin binding protein 35 appears to be an important molecule involved in recognition of the redox state of environmental conditions. In addition, TCmAb-h13 had an inhibitory effect on heme binding to recombinant HBP35, thereby interfering with P. gingivalis growth.
Collapse
Affiliation(s)
- Y Shibata
- Department of Biochemistry and Molecular Biology, Nihon University School of Dentistry at Matsudo, Chiba, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Kiyota N, Tahara M, Okano S, Kawashima M, Matsuura K, Onozawa Y, Nibu K, Hayashi R, Yoshimura K, Ohtsu A. Phase II feasibility trial of a 3-week cycle of cisplatin plus radiation for post-operative high-risk head and neck cancer in a Japanese population. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e16007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
29
|
Morioka A, Miyoshi Y, Tsuchiya F, Misawa H, Kasaba Y, Asozu T, Okano S, Kadokura A, Sato N, Miyaoka H, Yumoto K, Parks GK, Honary F, Trotignon JG, Décréau PME, Reinisch BW. On the simultaneity of substorm onset between two hemispheres. ACTA ACUST UNITED AC 2011. [DOI: 10.1029/2010ja016174] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- A. Morioka
- Planetary Plasma and Atmospheric Research Center; Tohoku University; Sendai Japan
| | - Y. Miyoshi
- Solar-Terrestrial Environment Laboratory; Nagoya University; Nagoya Japan
| | - F. Tsuchiya
- Planetary Plasma and Atmospheric Research Center; Tohoku University; Sendai Japan
| | - H. Misawa
- Planetary Plasma and Atmospheric Research Center; Tohoku University; Sendai Japan
| | - Y. Kasaba
- Geophysical Institute; Tohoku University; Sendai Japan
| | - T. Asozu
- Planetary Plasma and Atmospheric Research Center; Tohoku University; Sendai Japan
- Japan Atomic Energy Agency; Ibaraki Japan
| | - S. Okano
- Planetary Plasma and Atmospheric Research Center; Tohoku University; Sendai Japan
| | - A. Kadokura
- National Institute of Polar Research; Tokyo Japan
| | - N. Sato
- National Institute of Polar Research; Tokyo Japan
| | - H. Miyaoka
- National Institute of Polar Research; Tokyo Japan
| | - K. Yumoto
- Space Environment Research Center; Kyushu University; Fukuoka Japan
| | - G. K. Parks
- Space Sciences Laboratory; University of California; Berkeley California USA
| | - F. Honary
- Department of Physics; Lancaster University; Lancaster UK
| | - J. G. Trotignon
- Laboratoire de Physique et Chimie de l'Environnement et de l'Espace; Orléans France
| | - P. M. E. Décréau
- Laboratoire de Physique et Chimie de l'Environnement et de l'Espace; Orléans France
| | - B. W. Reinisch
- Center for Atmospheric Research; University of Massachusetts Lowell; Lowell Massachusetts USA
| |
Collapse
|
30
|
Tahara M, Araki K, Okano S, Kiyota N, Fuse N, Minashi K, Yoshino T, Doi T, Zenda S, Kawashima M, Ogino T, Hayashi R, Minami H, Ohtsu A. Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer. Ann Oncol 2011; 22:175-180. [PMID: 20530200 DOI: 10.1093/annonc/mdq298] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Tahara
- Division of Digestive Endoscopy and Gastrointestinal Oncology.
| | - K Araki
- Division of Hematology and Medical Oncology
| | - S Okano
- Division of Digestive Endoscopy and Gastrointestinal Oncology
| | - N Kiyota
- Division of Digestive Endoscopy and Gastrointestinal Oncology
| | - N Fuse
- Division of Digestive Endoscopy and Gastrointestinal Oncology
| | - K Minashi
- Division of Digestive Endoscopy and Gastrointestinal Oncology
| | - T Yoshino
- Division of Digestive Endoscopy and Gastrointestinal Oncology
| | - T Doi
- Division of Digestive Endoscopy and Gastrointestinal Oncology
| | - S Zenda
- Division of Radiation Oncology
| | | | - T Ogino
- Division of Radiation Oncology
| | - R Hayashi
- Division of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
| | - H Minami
- Division of Hematology and Medical Oncology
| | - A Ohtsu
- Division of Digestive Endoscopy and Gastrointestinal Oncology
| |
Collapse
|
31
|
Kondoh H, Okano S, Yoshida K, Yonemitsu Y, Tomita Y, Yoshikai Y, Wake N, Sueishi K. Semi-allogeneic dendritic cells injected via the intratumoural injection route show efficient antitumour effects in cooperation with host-derived professional antigen-presenting cells. Scand J Immunol 2010; 72:476-90. [PMID: 21044122 DOI: 10.1111/j.1365-3083.2010.02461.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Dendritic cells (DC)-based immunotherapy is a potent anticancer modality. In DC-based immunotherapy, allogeneic DC may be an alternative source, but the usefulness of allogeneic DC in DC-based immunotherapy is still controversial. When used for immunotherapy, three factors may affect the efficiency of an allogeneic DC-driven antitumour response: (1) survival time, which is affected by T-cell alloresponses; (2) major histocompatibility complex incompatibility with the host cells in the context of antigen presentation; and (3) the role of host-derived professional antigen-presenting cells (pAPC). In addition, it is unclear which injection route is preferable when using allogeneic DC. In this study, we demonstrate that semi-allogeneic DC, which share half of the genes of the recipient, are more effective when used via the intratumoural (i.t.) injection route, rather than the subcutaneous (s.c.) injection route, for the induction of efficient antitumour effects and the generation of a significant tumour-specific CD8(+) T-cell response. The i.t. route has the advantage of not requiring ex vivo pulsation with tumour lysates or tumour antigens, because the i.t.-injected DC can engulf tumour antigens in situ. Allogeneic bone marrow transplantation (BMT) models, which permit us to separately assess the three factors described previously, show that while all three factors are important for efficient antitumour effects, the control of the alloresponse to injected DC is the most crucial for host-derived pAPC to function well when DC are administered intratumourally. This information may be useful for DC-based cancer immunotherapy under circumstances that do not allow for the use of autologous DC.
Collapse
Affiliation(s)
- H Kondoh
- Division of Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Onzuka T, Tomita Y, Okano S, Shimizu I, Yamada H, Yoshikai Y, Tominaga R. Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice. Scand J Immunol 2010; 72:106-17. [PMID: 20618769 DOI: 10.1111/j.1365-3083.2010.02417.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We reported that invariant NKT-cell knockout (iNKT KO) mice are resistant to the induction of intrathymic chimerism and clonal deletion in the cyclophosphamide (CP)-induced tolerance system (CPS). However, another report shows that clonal deletion with chimerism may be intact in iNKT KO recipients in a bone marrow transplantation model. We also reported that pretreatment with anti-Thy1.2 mAb, which reduces the number of T cells and iNKT cells, promotes allograft tolerance across H-2 barriers in the CPS. In this study, we evaluated the efficacy of T-cell depletion in the CPS, and the relationship between the role played by iNKT cells in central tolerance and mixed chimerism. BALB/c (H-2(d)) wild-type, or iNKT KO (Jalpha18(-/-)) mice were pretreated with 20-100 microg of anti-Thy1.2 mAb and given 10(8) donor DBA/2 (H-2(d)) spleen cells on Day 0, and 200 mg/kg CP on Day 2. Pretreatment with T-cell depletion resulted in higher levels of mixed chimerism, increased intrathymic clonal deletion of donor-reactive cells, and the induction of skin graft tolerance in iNKT KO recipients in CPS. This suggests that the high levels of mixed chimerism overcame the resistance to CP-induced tolerance in iNKT KO mice. Consistently, the enhancement of mixed chimerism by injection of tolerant donor spleen cells (SC) rendered iNKT KO recipients susceptible to CP-induced tolerance. These results suggest that iNKT-cell-mediated immunoregulation of central tolerance is evident at low levels of peripheral mixed chimerism in the CPS.
Collapse
Affiliation(s)
- T Onzuka
- Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan
| | | | | | | | | | | | | |
Collapse
|
33
|
Meseguer M, Herrero J, Tejera A, de los Santos MJ, Escrich L, Garrido N, Ramsing N, Graham J, Richter K, Siques J, Vermilyea M, Widra E, Tucker M, Cauffman G, Verheyen G, Haentjens P, Devroey P, Liebaers I, Van de Velde H, Hiraoka K, Hiraoka K, Miyazaki M, Fukunaga E, Horiuchi T, Kusuda T, Okano S, Kinutani M, Kinutani K, Brugnon F, Bouraoui Z, Ouchchane L, Gremeau AS, Peikrishvili R, Pouly JL, Janny L. Session 41: Embryo Development & Implantation. Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.41] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Okano S, Nakane Y, Inoue K, Fujitani K, Kimura Y, Kogire M, Imano M, Shimokawa T, Kurokawa Y, Furukawa H. A phase II study of systemic chemotherapy with TS-1 combined with cisplatin followed by surgery in advanced gastric cancer (OGSG0004). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e14562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
35
|
Onzuka T, Tomita Y, Shimizu I, Okano S, Yamada H, Yoshikai Y, Tominaga R. Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance. Scand J Immunol 2009; 70:423-30. [PMID: 19874546 DOI: 10.1111/j.1365-3083.2009.02314.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Cyclophosphamide (CP)-induced tolerance is a mixed chimerism-based tolerance and is one of the strategies used to induce transplant tolerance. Toll-like receptor (TLR) agonists are reportedly able to abrogate the induction of tolerance by activating alloreactive T cells, or by inhibiting Treg cells. However, little is known about the effect of the immune response mediated by TLR on mixed chimerism-based tolerance protocols. In this study, we evaluated the influence of lipopolysaccharide (LPS), which is best known as an TLR4 agonist, on CP-induced tolerance. BALB/c (H-2(d)) mice received a conditioning regimen consisting of 10(8) donor DBA/2 (H-2(d)) spleen cells (SC) on day 0 and 200 mg/kg CP on day 2. A single dose of 20 microg LPS was injected on day -2, 0, 7, or 35. Our results showed that LPS infusion at any time point resulted in chronic rejection of donor skin grafts and the abrogation of mixed chimerism in 33-60% of recipients. We found a correlation between skin graft acceptance and higher levels of mixed chimerism. Flow cytometric analysis revealed that donor-reactive T cells were permanently eliminated, regardless of LPS infusion. In conclusion, LPS-infusion had little influence on the immune response of donor-reactive T cells, but had a significant effect on the induction and maintenance of mixed chimerism in CP-induced tolerance.
Collapse
Affiliation(s)
- T Onzuka
- Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka, Japan
| | | | | | | | | | | | | |
Collapse
|
36
|
Okano S, Tahara M, Zenda S, Kawashima M, Ogino T, Fuse N, Yoshino T, Doi T, Ohtsu A. 8539 Induction chemotherapy with docetaxel, cisplatin and S-1 (TPS) followed by proton therapy concurrent with cisplatin in the patients with T4 nasal cavity cancer. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71630-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
37
|
Tahara M, Araki K, Kiyota N, Okano S, Fuse N, Minashi K, Yoshino T, Doi T, Minami H, Ohtsu A. Final results of a phase I trial of chemotherapy combination with docetaxel, cisplatin, and S-1 (TPS) in patients with locally advanced or recurrent metastatic head and neck cancer (HNC). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.6021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
6021 Background: An oral fluoropyrimidine, S-1, has shown high efficacy against head and neck cancer (HNC), with a response rate of 34%. We investigated the maximum tolerated dose (MTD) of combination therapy with docetaxel, cisplatin and S-1 (TPS) in patients (pts) with locally advanced or recurrent/metastatic HNC. Methods: Eligibility criteria were histologically proven HNC, PS 0–1, age ≤75 years, adequate organ function, and no prior chemotherapy. Treatment consisted of 1-hour infusion of docetaxel at escalating doses of 50, 60 and 70 mg/m2, 2-hour infusion of cisplatin at 70 mg/m2/day on day 1, and S-1 twice daily on days 1–14 at escalating doses of 40, 60, and 80 mg/m2/day. This regimen was repeated every 3 or 4 weeks. Pts with locally advanced HNC received concurrent chemoradiotherapy after completion of 3 cycles of TPS. Results: Forty pts were enrolled, consisting of 33 males and 7 females with a median age of 50 years (range 22–74 years). Twenty-nine cases were locally advanced cancer and 11 were metastatic cancer. 116 cycles (median = 3, range 1–6) were administered in 6 dose levels. Grade 3 or 4 hematological toxicities were neutropenia (59%), febrile neutropenia (13%), and anemia (8%), whereas no grade 3 or 4 thrombocytopenia was seen. Two dose-limiting toxicities (DLTs) were observed at dose level 5 (TPS: 70/70/80 mg/m2/day every 3 weeks), namely one grade 3 infection and one grade 3 hyperbilirubinemia, establishing this as the MTD. Of 12 pts treated at dose level 6 (TPS: 70/70/60 mg/m2/day every 3 weeks), three DLTs were seen, namely one grade 3 diarrhea, one grade 3 ALT/AST and one grade 2 creatinine elevation. Of a total of 40 pts, 6 achieved a complete response and 22 a partial response according to RECIST, giving an overall response rate of 70%. Conclusions: The TPS combination was well tolerated. The recommended phase II dose was determined to be TPS at 70/70/60 mg/m2/day every 3 weeks. Antitumor activity was highly promising, and warrants further investigation. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- M. Tahara
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - K. Araki
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - N. Kiyota
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - S. Okano
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - N. Fuse
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - K. Minashi
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - T. Yoshino
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - T. Doi
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - H. Minami
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| | - A. Ohtsu
- National Cancer Center Hospital East, Kashiwa, Japan; Saitama Medical University, Hidaka, Saitama, Japan; Kobe University Hospital, Kobe, Japan
| |
Collapse
|
38
|
Li Z, Okano S, Yoshinari K, Miyamoto T, Yamazoe Y, Shinya K, Ioku K, Kasai N. Soft-hydrothermal processing of red cedar bedding reduces its induction of cytochrome P450 in mouse liver. Lab Anim 2009; 43:205-11. [DOI: 10.1258/la.2008.007146] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Red cedar-derived bedding materials cause changes in cytochrome P450-dependent microsomal enzyme systems in laboratory animals. We examined the effect of essential oil of red cedar (EORC), as well as the effect of bedding from which it had been removed, on the hepatic expression cytochrome P450s in mice. EORC was obtained from liquid extracts of red cedar bedding by a soft-hydrothermal process and was administered orally to mice. Between days 1 and 2 after administration, hepatic P450s were significantly induced as follows: CYP3As, 7.1×; CYP1As, 1.6×; CYP2E1, 1.5×; CYP2Cs, 1.6×. A housing study of mice indicated that red cedar bedding increased the levels of these P450s in mouse liver, whereas mice housed in cedar bedding from which EORC had been removed (ST-cedar bedding) showed significantly lower levels of P450s, especially CYP3As, CYP1As and CYP2E1. Soft-hydrothermal processing partially removed many components of EORC. In particular, several volatile sesquiterpenes, naphthalene-derived aromatics and 4,4-dimethyl-13α-androst-5-ene were decreased in the ST-cedar bedding, suggesting that these may be responsible for P450 induction. This study demonstrated that the removal of these volatile compounds by soft-hydrothermal processing can decrease the hepatic P450-inducing effect of red cedar bedding.
Collapse
Affiliation(s)
- Z Li
- Graduate School of Environmental Studies
| | - S Okano
- Institute for Animal Experimentation, Graduate School of Medicine
| | - K Yoshinari
- Graduate School of Pharmaceutical Sciences, Tohoku University, Japan
| | - T Miyamoto
- Institute for Animal Experimentation, Graduate School of Medicine
| | - Y Yamazoe
- Graduate School of Pharmaceutical Sciences, Tohoku University, Japan
| | - K Shinya
- International Center for Medical Research and Treatment, Graduate School of Medicine, Kobe University, Japan
| | - K Ioku
- Graduate School of Environmental Studies
| | - N Kasai
- Institute for Animal Experimentation, Graduate School of Medicine
| |
Collapse
|
39
|
Yoshimura M, Ohara N, Kondo Y, Shoji M, Okano S, Nakano Y, Abiko Y, Nakayama K. Proteome analysis of Porphyromonas gingivalis cells placed in a subcutaneous chamber of mice. ACTA ACUST UNITED AC 2008; 23:413-8. [PMID: 18793365 DOI: 10.1111/j.1399-302x.2008.00444.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
INTRODUCTION Porphyromonas gingivalis, an oral anaerobic bacterium, is considered a major pathogen for chronic periodontitis. Pathogenic bacteria usually upregulate or downregulate gene expression to combat the protective responses of their hosts. METHODS To determine what protein is regulated when P. gingivalis cells invade host tissues, we analyzed the proteome of P. gingivalis cells that were placed in a mouse subcutaneous chamber by two-dimensional gel electrophoresis and mass spectrometry. RESULTS Fourteen proteins were upregulated, while four proteins were downregulated. We focused on three upregulated proteins, PG1089 (DNA-binding response regulator RprY), PG1385 (TPR domain protein), and PG2102 (immunoreactive 61-kDa antigen), and constructed mutant strains that were defective in these proteins. Mouse abscess model experiments revealed that the mutant strain defective in PG1385 was clearly less virulent than the wild-type parent strain. CONCLUSION These results indicate that the PG1385 protein is involved in P. gingivalis virulence and that the method used here is useful when investigating the P. gingivalis proteins responsible for virulence.
Collapse
Affiliation(s)
- M Yoshimura
- Division of Microbiology and Oral Infection, Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Tanaka T, Tsukui R, Okano S, Tsuchiya M, Obokata K, Ogawa T, Abe T, Ikeya T, Miyasaki M. Continuous intravenous lidocaine controls abdominal pain secondary to peritoneal carcinomatosis as a consequence of diffusion into ascites. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.9031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
9031 Background: Our team reported at the 42nd ASCO meeting that continuous, low-dose intravenous (IV) lidocaine is an effective method for pain relief in terminal patients with peritoneal carcinomatosis. Our aim was to explore the mechanism by which abdominal pain of terminally-ill patients with peritoneal carcinomatosis was improved by continuous IV lidocaine. Methods: 48 patients with peritoneal carcinomatosis due to GI (46) and GYN (2) malignancies were administered lidocaine at low-doses (0.4 and/or 0.8mg/kg- h) for >24 hours, because opiates, NSAIDs, and other adjuvants were ineffective in relieving their abdominal pain. Pain (faces rating scale; 0-no pain, 5-worst pain), oral intake, side effects, and activities of daily life were quantified. Two days after beginning lidocaine, ascites was sampled to measure ascitic concentration of lidocaine, tumor markers and cytology. Results: Mean age (±SE) was 60±2. The volume of ascites was estimated to be 2,700±400ml by the ultrasound 5 points methodology. Abdominal symptoms improved in 1.5±0.2days after beginning lidocaine, and the pain scale decreased from 1.9±0.2 to 0.5±0.1; p<0.001; 75% of patients had improvement in pain of whom 78% had complete relief of pain. Oral intake increased from 18% to 49% of baseline (p<0.001), and 67% in those with improvement in pain had an increased volume of oral intake. There were no obvious differences in response to 0.4 and 0.8 mg/kg-h in patients receiving both doses. Serum concentrations of lidocaine at 0.4 and 0.8 mg/kg-h were 1.7±0.2 and 3.2±0.2 μg/ml, respectively; lidocaine concentrations in the ascites were 1.2±0.2 and 2.1±0.2 μg/ml. No patient complained of pain at the time of peritoneal puncture. Side effects included bradycardia of <60 beats per minutes (3 patients). The duration of lidocaine administration was 23±3 days; 43% of patients were able to be discharged home for end-of-life care, with parenteral nutrition and continuation of lidocaine administration or oral mexiletine (300–450 mg/day) for adjuvant analgesia. Conclusions: Lidocaine diffuses into ascites and almost equilibrates with serum concentrations acting as a peritoneal anesthesia which, as a result, controls abdominal pain in patients with peritoneal carcinomatosis. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- T. Tanaka
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - R. Tsukui
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - S. Okano
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - M. Tsuchiya
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - K. Obokata
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T. Ogawa
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T. Abe
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T. Ikeya
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - M. Miyasaki
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| |
Collapse
|
41
|
Tanaka S, Yonemitsu Y, Yoshida K, Okano S, Kondo H, Inoue M, Hasegawa M, Masumoto K, Suita S, Taguchi T, Sueishi K. Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice. Gene Ther 2007; 14:1017-28. [PMID: 17460720 DOI: 10.1038/sj.gt.3302955] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We demonstrated previously that the additive-type recombinant Sendai virus (rSeV) is highly efficient for use in pulmonary gene transfer; however, rSeV exhibits inflammatory responses. To overcome this problem, we tested newly developed non-transmissible constructs, namely, temperature-sensitive F-deleted vector, rSeV/dF (ts-rSeV/dF) and a rSeV with all the envelope-related genes deleted (rSeV/dFdMdHN), for pulmonary gene transfer in neonatal mice, by assessing their toxicity and immune responses. The gene expression in the lungs of neonatal ICR mice peaked on day 2, then gradually decreased until almost disappearing at 14 days after infection in all constructs. Loss of body weight and mortality rate, however, were dramatically improved in mice treated with SeV/dFdMdHN (mortality=0%, n=41) and ts-rSeV/dF (24.2%, n=33) compared with additive rSeV (70.7%, n=58). Although the deletion of envelope-related genes of SeV had a small impact on the production of antibody and cytotoxic T-lymphocyte activity in both adults and neonates, a dramatic reduction was found in the events related to innate responses, including the production of proinflammatory cytokines, particularly in the case of neonates. These results indicate that pulmonary gene transfer using SeV/dFdMdHN warrants further investigation for its possible use in developing safer therapeutics for neonatal lung diseases, including cystic fibrosis.
Collapse
Affiliation(s)
- S Tanaka
- Division of Pathophysiological and Experimental Pathology, Department of Pathology, Kyushu University, Fukuoka, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Tomita Y, Shimizu I, Iwai T, Zhang QW, Okano S, Kajiwara T, Onzuka T, Tominaga R. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation. Scand J Immunol 2006; 64:392-7. [PMID: 16970680 DOI: 10.1111/j.1365-3083.2006.01831.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The current critical shortage of human donor organs has stimulated the feasibility of the xenogenic transplantation, such as swine to primate. We have previously reported the induction of donor-specific tolerance in MHC-disparated recipient mice by using our cyclophosphamide (CP)-induced tolerance conditioning. In this study, we examined the efficacy of our CP-induced tolerance conditioning in xenogenic transplantation model. F344 rats and B10 mice were used as donors and recipients. Recipient mice were treated with donor spleen cells, CP, Busulfan and bone marrow cells, with or without prior NK-cell depletion. Donor mixed chimerism, and the presence of donor reactive T-cell population were analysed by flow cytometry. The survival of the donor skin grafts were observed after the conditioning. Donor mixed chimerism was temporary induced but terminated at 10 weeks after treatments. Donor-specific prolongation of the skin graft survival was observed after the treatments, however, grafts were rejected in the long term. NK-cell depletion, prior to the treatments, did not affect the levels of the mixed chimerism or graft prolongation. The donor-reactive recipient T-cell population was remained the same level as the untreated mice, suggesting the failure of the induction of the central T-cell tolerance. Thus, partial efficacy of our CP-induced tolerance treatments in the rat to mice xenotransplantation was observed. Our results suggested that the additional treatments were required to establish the stable xenogenic tolerance.
Collapse
Affiliation(s)
- Y Tomita
- Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Tanaka T, Okano S, Tsukui R, Tomaru M, Ueno M, Tsuchiya M, Obokata K, Saigo S, Ogawa T, Abe T, Ikeya T. Continuous low-dose intravenous lidocaine is effective for visceral pain secondary to peritoneal carcinomatosis in terminal cancer patients. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.8533] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8533 Background: Lidocaine, a local anesthetic, is often used as an anti-arrhythmic and as an analgesic of best support care (BSC) for patients with neuropathic pain. However, little is known about the effect of low-dose lidocaine on the abdominal pain of terminally-ill patients with peritoneal carcinomatosis. Aim: To evaluate whether visceral pain is controlled and activities of daily life (ADL) are improved during continuous lidocaine infusion. Methods: 28 terminally ill patients with peritoneal carcinomatosis due to the gastrointestinal (26) and gynecologic (2) cancers were studied. Despite aggressive pain management with opiates, non-steroidal anti-inflammatory drugs and other adjuvants, debilitating pain persisted. After a test dose of 2mg/kg intravenously, lidocaine was administered at low-doses (0.4 and/or 0.8mg/kg-h) through a vein and continued for more than 24 hours. Pain was quantitated on a faces rating scale from the level 0 (no pain) to 5 (severe pain); doses of opiates, amounts of oral intake, side effects, and ADL were measured before and after lidocaine. Results: Age (mean±SE) was 62±2, and percentage of males was 54%. Patients were not hypercalcemia but were slightly malnutrished (albumin 2.9±0.1g/dl) and anemic (hemoglobin 10.3±0.4g/dl). The duration of lidocaine administration in hospital was 18±3days. Abdominal symptoms improved within 1.2±0.1days after beginning lidocaine, and pain scale decreased from 2.7±0.2 to 0.6±0.2; p<0.001. In 68% of patients, the pain level became zero. Blood concentration of lidocaine at 0.8mg/kg-h was 3.0±0.4μg/ml 1 week later. 68% of patients needed no increase in opiate dosage during lidocaine administration. Waist size did not decrease, however, oral intake increased (p=0.002) during lidocaine administration. No obvious side effects, such as perioral numbness, were seen except for emotional lability noted in 4 patients. 43% patients were able to be discharged for continued end-of-life comfort care with home parenteral nutrition and continuation of lidocaine administration. Conclusions: We suggest that continuous, low-dose intravenous lidocaine is BSC and is a very effective approach for analgesia and improvement of ADL in patients with peritoneal carcinomatosis. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- T. Tanaka
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - S. Okano
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - R. Tsukui
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - M. Tomaru
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - M. Ueno
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - M. Tsuchiya
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - K. Obokata
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - S. Saigo
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T. Ogawa
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T. Abe
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T. Ikeya
- Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| |
Collapse
|
44
|
Nakano Y, Shibata Y, Kawada M, Kojima M, Fukamachi H, Shibata Y, Okano S, Matsushima K, Abiko Y, Yamashita Y. A searchable database for proteomes of oral microorganisms. ACTA ACUST UNITED AC 2005; 20:344-8. [PMID: 16238593 DOI: 10.1111/j.1399-302x.2005.00235.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
An online database of proteomes for two-dimensional electrophoresis (2DE) gel data was constructed and it is now freely accessible through a web-based interface. Proteins from three oral bacteria, Streptococcus mutans UA159, Actinobacillus actinomycetemcomitans HK1651, and Porphyromonas gingivalis W83, whose genome databases are freely available, were separated by 2DE, and protein spots were analyzed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) and identified. About 1000 spots from the gels of P. gingivalis W83 were extracted and analyzed by MALDI-TOF, and 330 proteins were identified. In addition, 160 of 240 spots of A. actinomycetemcomitans and 158 of 356 spots of S. mutans were identified. Information such as spot coordinates on the gels, protein names (predicted functions), molecular weights, isoelectroric points, and links to online databases, including Oral Pathogen Sequence Databases of the Los Alamos National Laboratory Bioscience Division (ORALGEN) and National Center for Biotechnology Information (NCBI) or The Institute Genomic Research (TIGR), were stored in tables accessible through the relational database management system MySQL on an Apache web server. To test for functionality of this database system, responses of S. mutans to environmental changes were analyzed using the database and 21 spots on the gel were identified as proteins whose expression had been increased or decreased by environmental pH change without in-gel trypsin digestion, protein extraction, or MALDI-TOF/TOF-MS (mass spectrometer) analysis. The identified proteins are agreement with those reported in previous papers on acid tolerance of S. mutans, demonstrating the usefulness of the system. This database is available at http://www.myamagu.dent.kyushu-u.ac.jp/~bioinformatics/index.html or http://www.bipos.mascat.nihon-u.ac.jp/index.html.
Collapse
Affiliation(s)
- Y Nakano
- Department of Preventive Dentistry, Kyushu University Faculty of Dental Science, Fukuoka, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Shimizu I, Tomita Y, Iwai T, Kajiwara T, Okano S, Sueishi K, Nomoto K, Yasui H. Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen. Scand J Immunol 2005; 62:271-80. [PMID: 16179014 DOI: 10.1111/j.1365-3083.2005.01644.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In the present study, we have elucidated the efficacy of two cyclophosphamide (CP)-induced tolerance protocols for the induction of B-cell tolerance against Galalpha1-3Galbeta1-4GlcNAc (alphaGal) antigens. alpha1,3-galactosyltransferase-deficient (GalT-/-; H-2(b/d)) mice received with 1 x 10(8) AKR (alphaGal+/+ H-2k) spleen cells (SC) followed by 200 mg/kg CP, or alternatively followed by 200 mg/kg CP, 30 mg/kg Busulfan (BU) and 1 x 10(8) T-cell-depleted AKR bone marrow cells (BMC). The generation of both anti-alphaGal and anti-donor antibodies were completely suppressed, but normal antibody production against third party antigens was observed after BALB/c skin grafting in both groups of GalT-/- mice. In GalT-/- mice, treated with SC and CP, mixed chimerism was not observed. Cellular rejection was observed in grafted donor AKR hearts with an absence of humoral rejection, whereas humoral rejection was observed in untreated GalT-/- mice. On the other hand, long-term mixed chimerism and permanent acceptance of donor AKR skin graft and heart graft were achieved in GalT-/- mice treated with SC, CP, BU and BMC. These results demonstrate the efficacy of classical drug-induced tolerance in the induction of B-cell tolerance against alphaGal antigens. However, induction of stable mixed chimerism was required for the suppression of cellular rejection.
Collapse
Affiliation(s)
- I Shimizu
- Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu Institute of Bioregulation, Kyushu University, Fukuoka, Japan
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Okano S, Yonemitsu Y, Nagata S, Sata S, Onimaru M, Nakagawa K, Tomita Y, Kishihara K, Hashimoto S, Nakashima Y, Sugimachi K, Hasegawa M, Sueishi K. Recombinant Sendai virus vectors for activated T lymphocytes. Gene Ther 2003; 10:1381-91. [PMID: 12883535 DOI: 10.1038/sj.gt.3301998] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
T-lymphocyte-directed gene therapy has potential as a treatment of subjects with immunological disorders. One current limitation of this therapeutic strategy is low gene transfer efficiency, even when complex procedures are used. We report herein that a recombinant Sendai virus vector (SeV) was able to overcome this issue. Using jellyfish enhanced green fluorescent protein gene (EGFP), we found that SeV was able to transduce and express a foreign gene specifically and efficiently in activated murine and human T cells, but not in naive T cells, without centrifugation or reagents including polybrene and protamine sulfate; the present findings were in clear contrast to those demonstrated with the use of retroviruses. The transduction was selective in antigen-activated T cells, while antigen-irrelevant T cells were not transduced, even under bystander activation from specific T-cell responses by antigens ex vivo. Receptor saturation studies suggested a possible mechanism of activated T-cell-specific gene transfer, ie, SeV might attach to naive T cells but might be unable to enter their cytoplasm. We therefore propose that the SeV vector system may prove to be a potentially important alternative in the area of T-cell-directed gene therapy used in the clinical setting.
Collapse
Affiliation(s)
- S Okano
- Division of Pathophygiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, Takeshita H, Hasegawa M, Sueishi K, Hara T. Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells. Gene Ther 2003; 10:272-7. [PMID: 12571635 DOI: 10.1038/sj.gt.3301877] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Hematopoietic stem cells (HSCs) are a promising target for gene therapy, however, the low efficiencies of gene transfer using currently available vectors face practical limitations. We have recently developed a novel and efficient gene transfer agent, namely recombinant Sendai virus (SeV), and we have here characterized SeV-mediated gene transfer to human cord blood (CB) HSCs and primitive progenitor cells (PPC) using the jelly fish green fluorescent protein (GFP) gene. Even at a relatively low titer (10 multiplicity of infections), SeV achieved highly efficient GFP expression in CB CD34(+) cells (85.5+/-5.8%), as well as more immature CB progenitor cells, CD34(+)AC133(+) (88.2+/-3.7%) and CD34(+)CD38(-) (84.6+/-5.7%) cells, without cytokines prestimulation, that was a clear contrast to the features of gene transfer using retroviruses. SeV-mediated gene transfer was not seriously affected by the cell cycle status. In vitro cell differentiation studies revealed that gene transfer occurred in progenitor cells of all lineages (GM-CFU, 73.0+/-11.1%; BFU-E, 24.7+/-4.0%; Mix-CFU, 59+/-4.0%; and total, 50.0+/-7.0%). These findings show that SeV could prove to be a promising vector for efficient gene transfer to CB HSCs, while preserving their ability to reconstitute the entire hematopoietic series.
Collapse
Affiliation(s)
- C H Jin
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Shoji F, Yonemitsu Y, Okano S, Yoshino I, Nakagawa K, Nakashima Y, Hasegawa M, Sugimachi K, Sueishi K. Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice. Gene Ther 2003; 10:213-8. [PMID: 12571628 DOI: 10.1038/sj.gt.3301847] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Bronchiolitis obliterans (BO) after lung transplantation prevents a satisfactory prognosis, and recent studies suggested that interleukin-10 (IL-10) gene transfer to distant organs could inhibit BO in rodent models. Although delivery of the therapeutic gene to a local airway would be favored to minimize systemic effects, current limitations include lower gene transfer efficiency to airway epithelium. As recombinant Sendai virus (SeV) can produce dramatically efficient gene transfer to airway epithelium, we determined if SeV-mediated IL-10 gene transfer to the local airway would inhibit bronchial fibrous obliteration in murine tracheal allografts. Administration of cyclosporine A (CsA) significantly promoted not only recovery of the injured airway epithelium but also SeV-mediated IL-10 expression (CsA- versus CsA+ =228+/-78 versus 3627+/-1372 pg/graft with 5 x 10(7) pfu), thereby suggesting the requirement of epithelia for efficient gene transfer. Even at the highest expression, no significant leakage of IL-10 was evident in the systemic circulation, and the induction of interferon-gamma was completely diminished on day 7 by IL-10 gene transfer. As a result, luminal loss was significantly prevented in allografts treated with SeV-IL-10 (luminal opening, all control groups: 0% respectively, and SeV-IL-10 5 x 10(7) pfu: 25.7+/-10.5%), an effect that was enhanced by short-term CsA treatment (SeV-IL-10 5 x 10(7) pfu with CsA: 63.7+/-12.7%). We propose that SeV is a useful vector that can target airway epithelium to prevent BO avoiding putative systemic effect.
Collapse
Affiliation(s)
- F Shoji
- Division of Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Okano S, Yoshida M, Fukushima U, Higuchi S, Takase K, Hagio M. Usefulness of systemic inflammatory response syndrome criteria as an index for prognosis judgement. Vet Rec 2002; 150:245-6. [PMID: 11916026 DOI: 10.1136/vr.150.8.245] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Affiliation(s)
- S Okano
- Department of Small Animal Medicine, School of Veterinary Medicine and Animal Sciences, Kitasato University, Towada, Aomori, Japan
| | | | | | | | | | | |
Collapse
|
50
|
El-Shazly S, Okano S, Asano A, Watanabe T. Developmental study of the different effects on the hybrid sterility of Kit and KitW-v alleles paired with Kit from Mus spretus. Dev Growth Differ 2001; 43:611-7. [PMID: 11576178 DOI: 10.1046/j.1440-169x.2001.00598.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The combination of the KitW or KitW-n mutant alleles and KitS from Mus spretus results in male hybrid sterility with small testes. In the present study, reproduction of the combination between KitW-v and KitS alleles was examined. The KitW-v/KitS male was fertile and the histologic structure was normal; the seminiferous tubules showed all of the normal stages of spermatogenesis. The postnatal development of the testis at 8, 12, 16 and 20 days was also studied in the fertile +Kit/+Kit and KitW-v/KitS males and the sterile KitW/KitS. The results showed that at 8 days there was no noticeable difference among the three genotype combinations, while from 12 to 20 days spermatogenesis in the KitW/KitS male nearly stopped before the meiosis stage. The expression of Kit receptor protein from the KitS allele in the sterile testis of the KitW/KitS male was confirmed using western blot analysis. The Kit ligand derived from M. spretus showed two amino acid changes in the extracellular domain compared with that from C57BL and it appears that the ligand-receptor interaction between C57BL and SPR may influence the male hybrid sterility of KitW/KitS.
Collapse
Affiliation(s)
- S El-Shazly
- Laboratory of Experimental Animal Science, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan
| | | | | | | |
Collapse
|